13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001601086
Total reported value
$8.2B
$8.2B
359 檔
56.1%
In Q4 2025, Armistice Capital, LLC's U.S. equity holdings reached a combined market value of $8.2B, distributed across 359 disclosed stock positions.
In Q4 2025, Armistice Capital, LLC displayed an active expansion posture, initiating 49 new positions and adding to 78 existing holdings, outstripping position reductions.
Showing top 200 holdings (of 359 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 24.34% | +4.96% | +20.00% | |
| 2 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 23.72% | +5.89% | +15.71% | |
| 3 | PTCT | Ptc Therapeutics Inc | Stock-Healthcare | 2.53% | -1.26% | -14.51% | |
| 4 | IMVT | Immunovant Inc | Stock-Other | 1.97% | -1.03% | +11.33% | |
| 5 | AGIO | Agios Pharmaceuticals Inc | Stock-Other | 1.95% | -1.19% | +262.74% | |
| 6 | CYTK | Cytokinetics Inc | Stock-Healthcare | 1.88% | -0.27% | +16.11% | |
| 7 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 1.84% | -0.57% | +6.29% | |
| 8 | TVTX | Travere Therapeutics Inc | Stock-Other | 1.71% | -1.15% | -44.02% | |
| 9 | SUPN | Supernus Pharmaceuticals Inc | Stock-Healthcare | 1.63% | -0.23% | -2.54% | |
| 10 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 1.38% | -0.60% | +17.68% | |
| 11 | INCY | Incyte CORP | Stock-Healthcare | 1.29% | +0.15% | -5.94% | |
| 12 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 1.01% | -0.14% | +18.82% | |
| 13 | S | Sentinelone Inc -class A | Stock-Tech | 1.00% | -0.23% | +123.89% | |
| 14 | XRAY | Dentsply Sirona Inc | Stock-Healthcare | 0.99% | -0.14% | +27.23% | |
| 15 | FRPT | Freshpet Inc | Stock-Consumer Staples | 0.94% | -0.24% | +4.96% | |
| 16 | FIVN | Five9 Inc | Stock-Tech | 0.91% | -0.37% | +43.40% | |
| 17 | KVUE | Kenvue Inc | Stock-Consumer Staples | 0.82% | -0.01% | EXIT | |
| 18 | GEHC | GE Healthcare Technology | Stock-Healthcare | 0.77% | -0.15% | EXIT | |
| 19 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 0.77% | +0.19% | -32.91% | |
| 20 | DYN | Dyne Therapeutics Inc | Stock-Other | 0.76% | -0.18% | +6.06% | |
| 21 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 0.73% | -0.06% | -14.85% | |
| 22 | MSFT | Microsoft CORP | Stock-Tech | 0.68% | +0.05% | +35.64% | |
| 23 | IRWD | Ironwood Pharmaceuticals Inc | Stock-Other | 0.64% | -0.22% | -0.77% | |
| 24 | KURA | Kura Oncology Inc | Stock-Other | 0.61% | -0.05% | +5.65% | |
| 25 | ELF | Elf Beauty Inc | Stock-Consumer Staples | 0.60% | +0.08% | +394.85% | |
| 26 | GSK | Gsk Plc-spon Adr | Stock-Healthcare | 0.58% | -0.04% | — | |
| 27 | ARGX | Argenx Se - Adr | Stock-Healthcare | 0.58% | — | — | |
| 28 | BABA | Alibaba Group Holding-sp Adr | Stock-Consumer Disc | 0.56% | -0.26% | +104.55% | |
| 29 | SBUX | Starbucks CORP | Stock-Consumer Disc | 0.55% | +0.09% | NEW | |
| 30 | PENN | Penn Entertainment Inc | Stock-Consumer Disc | 0.54% | -0.48% | +47.17% | |
| 31 | OFIX | Orthofix Medical Inc | Stock-Other | 0.48% | -0.19% | +18.43% | |
| 32 | IRON | Disc Medicine Inc | Stock-Other | 0.47% | -0.20% | +14.54% | |
| 33 | IMCR | Immunocore Holdings Plc-adr | Stock-Other | 0.45% | -0.09% | +33.25% | |
| 34 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 0.43% | -0.05% | +14.22% | |
| 35 | AVNS | Avanos Medical Inc | Stock-Other | 0.43% | -0.50% | EXIT | |
| 36 | RIGL | Rigel Pharmaceuticals Inc | Stock-Other | 0.43% | +0.18% | +15.47% | |
| 37 | AUTL | Autolus Therapeutics PLC | Stock-Other | 0.41% | -0.10% | +12.18% | |
| 38 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 0.41% | -0.19% | +48.96% | |
| 39 | DDOG | Datadog Inc - Class A | Stock-Tech | 0.40% | -0.32% | +21.02% | |
| 40 | VERA | Vera Therapeutics Inc | Stock-Other | 0.39% | -0.05% | +21.98% | |
| 41 | SNY | Sanofi-adr | Stock-Healthcare | 0.39% | +0.30% | +10.46% | |
| 42 | GTLB | Gitlab Inc-cl A | Stock-Tech | 0.38% | +0.10% | +127.92% | |
| 43 | AXGN | Axogen Inc | Stock-Other | 0.36% | -0.11% | -22.00% | |
| 44 | ANRO | Alto Neuroscience Inc | Stock-Other | 0.33% | -0.08% | -6.11% | |
| 45 | VSTM | Verastem Inc | Stock-Other | 0.32% | -0.10% | +68.70% | |
| 46 | HUBS | Hubspot Inc | Stock-Tech | 0.32% | -0.16% | +51.05% | |
| 47 | MDT | Medtronic plc | Stock-Healthcare | 0.31% | — | NEW | |
| 48 | GRFS | Grifols Sa-adr | Stock-Other | 0.31% | -0.18% | +23.79% | |
| 49 | NKTR | Nektar Therapeutics | Stock-Other | 0.30% | -0.12% | +122.39% | |
| 50 | NKE | Nike Inc -cl B | Stock-Consumer Disc | 0.30% | -0.13% | +399.04% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | AGIO | Agios Pharmaceuticals Inc | +1% | +262.74% | Add |
| 2 | IMVT | Immunovant Inc | +0.6% | +11.33% | Add |
| 3 | S | Sentinelone Inc -class A | +0.3% | +123.89% | Add |
| 4 | ELF | Elf Beauty Inc | +0.3% | +394.85% | Add |
| 5 | IRWD | Ironwood Pharmaceuticals Inc | +0.3% | -0.77% | Trim |
| 6 | ANRO | Alto Neuroscience Inc | +0.2% | -6.11% | Trim |
| 7 | NKE | Nike Inc -cl B | +0.2% | +399.04% | Add |
| 8 | DHR | Danaher CORP | +0.2% | +239.17% | Add |
| 9 | DYN | Dyne Therapeutics Inc | +0.2% | +6.06% | Add |
| 10 | VERA | Vera Therapeutics Inc | +0.2% | +21.98% | Add |
| 11 | BABA | Alibaba Group Holding-sp Adr | +0.2% | +104.55% | Add |
| 12 | CROX | Crocs Inc | +0.2% | +468.55% | Add |
| 13 | MDGL | Madrigal Pharmaceuticals Inc | +0.1% | +6.29% | Add |
| 14 | ISRG | Intuitive Surgical Inc | +0.1% | +48.96% | Add |
| 15 | CYTK | Cytokinetics Inc | +0.1% | +16.11% | Add |
| 16 | RIGL | Rigel Pharmaceuticals Inc | +0.1% | +15.47% | Add |
| 17 | GTLB | Gitlab Inc-cl A | +0.1% | +127.92% | Add |
| 18 | EW | Edwards Lifesciences CORP | +0.1% | +89.31% | Add |
| 19 | SBUX | Starbucks CORP | +0.1% | +54.39% | Add |
| 20 | ARVN | Arvinas Inc | +0.1% | +50.00% | Add |
| 21 | UBER | Uber Technologies Inc | +0.1% | +134.48% | Add |
| 22 | SLDB | Solid Biosciences Inc | +0.1% | +179.06% | Add |
| 23 | BILL | Bill Holdings Inc | +0.1% | +127.68% | Add |
| 24 | FLUT | Flutter Entertainment plc | +0.1% | +3517.66% | Add |
| 25 | BBOT | Bridgebio Oncology Therapeut | +0.1% | +142.72% | Add |
| 26 | COR | Cencora Inc | +0.1% | +298.12% | Add |
| 27 | NKTR | Nektar Therapeutics | +0.1% | +122.39% | Add |
| 28 | VRCA | Verrica Pharmaceuticals Inc | +0.1% | +75.05% | Add |
| 29 | VSTM | Verastem Inc | +0.1% | +68.70% | Add |
| 30 | SCLX | Scilex Holding Co | +0.1% | +622.23% | Add |
| 31 | IRON | Disc Medicine Inc | 0% | +14.54% | Add |
| 32 | AXGN | Axogen Inc | 0% | -22.00% | Trim |
| 33 | RDDT | Reddit Inc-cl A | 0% | +51.38% | Add |
| 34 | LEN | Lennar Corp-a | 0% | +92.61% | Add |
| 35 | MCK | Mckesson CORP | 0% | +94.14% | Add |
| 36 | SYRE | Spyre Therapeutics Inc | 0% | +25.91% | Add |
| 37 | TMO | Thermo Fisher Scientific Inc | 0% | +14.22% | Add |
| 38 | AUTL | Autolus Therapeutics PLC | 0% | +12.18% | Add |
| 39 | PATH | Uipath Inc - Class A | 0% | +13.41% | Add |
| 40 | WYNN | Wynn Resorts LTD | 0% | +50.66% | Add |
| 41 | FDMT | 4d Molecular Therapeutics In | 0% | +76.64% | Add |
| 42 | WDAY | Workday Inc-class A | 0% | +54.20% | Add |
| 43 | HUM | Humana Inc | 0% | +39.60% | Add |
| 44 | PEGA | Pegasystems Inc | 0% | +52.02% | Add |
| 45 | MSFT | Microsoft CORP | 0% | +35.64% | Add |
| 46 | IMCR | Immunocore Holdings Plc-adr | 0% | +33.25% | Add |
| 47 | HUBS | Hubspot Inc | 0% | +51.05% | Add |
| 48 | 260 | Centessa Pharmaceuticals-adr | 0% | +32.28% | Add |
| 49 | BSX | Boston Scientific CORP | 0% | +42.13% | Add |
| 50 | ZETA | Zeta Global Holdings Corp-a | 0% | +37.21% | Add |
According to official SEC Form 13F filings, Armistice Capital, LLC reported a total U.S. public equity portfolio value of $8.2B across 359 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SPY, IWM, PTCT) accounted for 56.1% of total reported equity market value during Q4 2025.
Top New Position Initiated
KVUE
市值: $68.9M
Top Position Liquidated / Trimmed
EXK
前期市值: $56.4M
During Q4 2025, Armistice Capital, LLC's top holdings by market value included SPY (24.3%)、IWM (23.7%)、PTCT (2.5%). The largest single position, SPY, represented 24.3% of total portfolio value.
In Q4 2025, Armistice Capital, LLC made 198 total portfolio adjustments, initiating 49 new buys, adding to 78 positions, trimming 31 holdings, and fully liquidating 40 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.